DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

In a Phase III trial, 28 percent of newly diagnosed patients with H3 K27M-mutant diffuse glioma responded to treatment with dordaviprone.

The glue made by scientists from MIT could prove to be a viable alternative to the other offerings in the market for biomedical use.

Spend a single day outside our planet's protective atmosphere and magnetic field, and you could be exposed to radiation ...